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ABSTRACT 
Background: Evidence on aerosol delivery via tracheostomy is lacking. The purpose of this 
study was to evaluate the effect of aerosol device and administration technique on drug delivery 
in a simulated spontaneously breathing pediatric model with tracheostomy. 
Methods: Delivery efficiencies during spontaneous breathing with assisted and unassisted 
administration techniques were compared using the jet nebulizer (JN- MicroMist), vibrating 
mesh nebulizer (VMN- Aeroneb Solo) and pressurized metered-dose inhaler (pMDI- 
ProAirHFA). The direct administration of aerosols in spontaneously breathing patients 
(unassisted technique) was compared to administration of aerosol therapy via a manual 
resuscitation bag (assisted technique) attached to the aerosol delivery device and synchronized 
with inspiration. An in-vitro lung model consisted of an uncuffed tracheostomy tube (4.5 mmID) 
was attached to a collecting filter (Respirgard) which was connected to a dual-chamber test lung 
(TTL) and a ventilator (Hamilton). The breathing parameters of a 2 years-old child were set at an 
RR of 25 breaths/min, a Vt of 150 mL, a Ti of 0.8 sec and PIF of 20 L/min. Albuterol sulfate was 
administered with each nebulizer (2.5 mg/3 ml) and pMDI with spacer (4 puffs, 108 µg/puff). 
Each aerosol device was tested five times with both administration techniques (n=5). Drug 
collected on the filter was eluted with 0.1 N HCl and analyzed via spectrophotometry. 
Results: The amount of aerosol deposited in the filter was quantified and expressed as inhaled 
mass and inhaled mass percent. The pMDI with spacer had the highest inhaled mass percent, 
while the VMN had the highest inhaled mass. The results of this study also found that JN had the 
least efficient aerosol device used in this study. The trend of higher deposition with unassisted 
versus assisted administration of aerosol was not significant (p>0.05).  
Conclusions: Drug deposited distal to the tracheostomy tube with JN was lesser than either 
VMN or pMDI. Delivery efficiency was similar with unassisted and assisted aerosol 
administration technique in this in vitro pediatric model.  
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CHAPTER I 
INTRODUCTION 
Over the years, aerosol therapy has come to play an integral role in the treatment of 
pediatric respiratory diseases. Inhaled aerosol agents such as bronchodilators, corticosteroids, 
antibiotics, and mucolytics are commonly delivered to spontaneously breathing pediatric patients 
with a tracheostomy. Administering therapeutic inhaled aerosols to pediatric patients is 
challenging. The pediatric population ranges in age, which means patients with different airway 
sizes, breathing patterns, and cooperation levels (Schüepp, Straub, Möller, & Wildhaber, 2004). 
These patient-related factors impact the deposition of aerosol drugs in the lungs (Ari & Fink, 
2011; Schüepp et al., 2004). The presence of an artificial airway such as a tracheostomy tube 
(TT) or an endotracheal tube also influences the deposition of inhaled aerosols in the lungs (Ari, 
Harwood, Sheard, & Fink, 2012). Therefore, it is important to select an efficient aerosol delivery 
device and the proper administration technique to enhance aerosol deposition in pediatric 
patients with a tracheostomy. 
Aerosol delivery devices, such as jet nebulizers (JN) and pressurized metered dose 
inhalers (pMDI) are the most common means of providing therapeutic inhaled aerosols to 
pediatric patients with a tracheostomy (Willis & Berlinski, 2012). In addition, the vibrating mesh 
nebulizer (VMN) is one of a group of new devices that has revolutionized the delivery of aerosol 
drugs. Each of these devices (JN, pMDI and VMN) can be used either alone (unassisted 
technique) or in conjunction with a manual resuscitation bag (assisted technique) to aid aerosol 
delivery. Health care providers need information about the best way to deliver aerosol drugs to 
pediatric patients who have a tracheostomy. Therefore, this study compares the amount of 
aerosol drugs deposited in the lungs by each of these three aerosol delivery devices when using 
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either the assisted or unassisted technique. This comparison can guide health care providers in 
selecting the optimum method for aerosol delivery to pediatric patients with a tracheostomy, 
which may result in a reduced drug dosage, a shorter treatment time, and a lower overall cost.  
Few in vivo and in vitro studies have examined the delivery of aerosol therapy to 
spontaneously breathing pediatric patients with a tracheostomy. By contrast, many researchers 
have studied the administration of inhaled aerosols to either spontaneously breathing patients or 
to mechanically ventilated patients through endotracheal tubes (Dhand, 2000, 2004; Duarte, 
Fink, & Dhand, 2001; MacIntyre, 2002). To date, researchers have yet to determine which 
device should be used among the pediatric patient population to optimize aerosol deposition via a 
TT and no published study has evaluated the efficiency of a VMN as an aerosol delivery device 
in spontaneously breathing pediatric patients with TTs. More research is needed that compares 
assisted and unassisted administrative techniques on aerosol delivery to such patients. Therefore, 
this study examines the efficiency of three different types of aerosol devices– a JN, a VMN, and 
a pMDI– on aerosol deposition in a simulated spontaneously breathing pediatric model with a 
tracheostomy. This research is also designed to compare the influence of assisted and unassisted 
aerosol administration techniques on the amount of aerosol delivered to the pediatric model 
developed in this study. 
The following research questions provide the structure for this study:  
1) What is the most efficient device for administering inhaled bronchodilators through a 
pediatric TT (JN, VMN or pMDI)?  
2) What is the best technique to administer inhaled bronchodilators via a pediatric TT 
(assisted or unassisted technique)?  
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CHAPTER II 
LITERATURE REVIEW 
This literature review presents articles focusing on the delivery of aerosol therapy 
through a pediatric TT. The following search terms were used to collect articles from the 
Cumulative Index to Nursing and Allied Health Literature (CINAHL) and PubMed databases: 
tracheostomy, pediatric, aerosol, nebulizer, breath-enhanced nebulizer, breath-activated 
nebulizer, metered dose inhaler and vibrating mesh nebulizer. Relevant articles are presented in 
two sections: (1) current practice for delivering aerosol through a pediatric tracheostomy and (2) 
aerosol generators, which describes and compares different aerosol delivery devices including a 
JN, a VMN, and pMDI. A discussion of in vitro comparison studies follows.  
Current Practice for Delivering Aerosol Through a Pediatric Tracheostomy 
There are no available recommendations for device and drug formulation selection for 
spontaneously breathing pediatric patients with a tracheostomy. Therefore, Willis and Berlinski 
(2012) developed a survey to describe patterns in current practice for delivering aerosol to this 
population. They surveyed pediatric pulmonologists at U.S. hospitals. The survey addressed 
institution characteristics, types of aerosol delivery devices and their administration technique, 
types of inhalation medication and factors influencing device selection. The researchers had an 
81% response rate (38 out of 47 institutions surveyed responded). Of these institutions, 68% 
were freestanding children’s hospitals. Results showed diversity among institutions in how 
aerosol to spontaneously breathing pediatric patients with a tracheostomy delivered. However, 
the authors found little variation in practice between the freestanding children’s hospitals and the 
other types of institutions. Most of the institutions used a nebulizer or a pMDI (97% and, 92%, 
respectively). No institution reported using dry powder inhalers. Nebulizers were administered 
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using both assisted and unassisted techniques. Although there was a discrepancy in the article 
regarding the number of institutions using either technique, most of the institutions used the 
unassisted technique with the nebulizer. The types of nebulizers used by the institutions were the 
followings: JNs (34 institutions), breath actuated nebulizers (BAN, four institutions operated the 
BAN continuously), breath-enhanced nebulizers (BEN, two institutions, one of which removed 
the inspiratory valve), and VMNs (one institution). Furthermore, pMDIs were used with either an 
assisted technique (32%, all of which used a spacer) or an unassisted technique (34% with 83% 
of them using a valved holding chamber, while the remaining using spacer) or both techniques 
(34%). The assisted technique was used by 68% of the surveyed institutions with either a 
nebulizer or a pMDI. Of these, 38% used a flow-inflating bag only, 31% used a self-inflating bag 
only, and 31% used both types of bags. As stated earlier, this survey showed that there was a 
considerable variation among institutions in the practice of aerosol delivery to spontaneously 
breathing tracheostomized children. However, it did not provide information about the most 
efficient aerosol delivery method to this population. Thus, the authors stressed the need for 
studies that compare the effect of using different aerosol devices and techniques on aerosol 
deposition in this population. 
Aerosol Generators 
According to the Willis and Berlinski survey (2012) described above, several aerosol 
generators are used to deliver inhaled medications to spontaneously breathing pediatric patients 
with a tracheostomy, including JNs, BENs, BANs, VMNs and pMDIs with a spacer or valved 
holding chamber. This section only describes the JN, VMN, and pMDI because these are the 
aerosol generators that will be tested in this study. The advantages and disadvantages of these 
generators will be reviewed to help respiratory care providers select the proper device for each 
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individual patient. Finally, this section will examine in vitro studies that have compared the 
effects of these aerosol generators on aerosol deposition in a spontaneously breathing pediatric 
model with a tracheostomy.  
Jet Nebulizer (JN) 
A JN is used to convert an aqueous solution containing a medication into an aerosol form. 
It is pneumatically operated by directing a pressurized gas created from a compressed gas source 
through a restricted orifice called a jet. The high velocity of the gas flow creates a jet stream that 
causes a sub-atmospheric pressure zone. This sub-atmospheric pressure draws liquid up the 
capillary tube from the nebulizer reservoir and into the gas stream. In the gas stream, the liquid is 
sheared into filaments that break up into droplets. These droplets can be further broken into small 
particles by a baffle in the aerosol stream (Hess, 2008). 
JNs can be used by any age group, including infants and small children, because they 
require minimal cooperation from the patient to deliver the medications (Ari, Hess, Myers, & 
Rau, 2009). They can be administered via either a mouthpiece or a face mask. The mouthpiece is 
recommended for use with spontaneously breathing children who have intact airways, who are 
more than three years old, and who are able to cooperate (Ari & Restrepo, 2012). The face mask 
is an appropriate interface to be used with young children, particularly those under three years 
old (Ari & Restrepo, 2012). A T-connector and tracheostomy collar are the interfaces that can be 
used with JNs for children with artificial airways such as a TT.  
A JN is also able to nebulize more than one drug or solution containing many drugs (Ari 
et al., 2009). However, it requires a longer treatment time than other aerosol devices, a power 
supply, and routine cleaning. Also, it wastes medication during exhalation (Ari et al., 2009). 
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Vibrating Mesh Nebulizer (VMN) 
VMNs use electricity to vibrate a mesh plate or aperture plate. The aperture plate 
contains multiple funnel-shaped holes with the wider cross-section facing towards the 
medication, and the narrower cross-section facing the place where the droplets emerge. The size 
of these funnel-shaped holes controls the size and flow of the nebulized particles. As the aperture 
plate begins to vibrate, the medication passes through the holes to generate aerosol. VMNs use 
either vibrating mesh (eg., Aerogen  Aeroneb, Nektar, San Carlos, CA; eFlow, Pari, Richmond, 
Virginia) or a vibrating horn (eg., Omron, Omron Healthcare, Bannockburn, IL) to produce 
vibrations in the aperture plate (Ari et al., 2009; Dhand, 2002; Hess, 2008).   
A VMN is small, portable, and compact and operates silently. Also, it has a minimal 
residual volume and a rapid nebulization rate, which means a faster nebulization time. On the 
downside, it is more expensive than a JN, and it cannot nebulize drug suspensions or viscous 
drugs, which can clog the holes. Moreover, it requires regular cleaning with gentle handling to 
the mesh to prevent blockage of the holes (Rubin, 2011). 
Pressurized Metered Dose Inhaler (pMDI) 
pMDI is a pressurized canister containing a mixture of drug and propellant that is fitted to 
a mouthpiece. Actuation of the canister opens a metering valve that releases a metered dose of 
drug in aerosolized form under the force of a pressurized propellant (Newman, 2005). The pMDI 
has many advantages. It is a small, portable, light, quiet, fast and relatively inexpensive device 
(Hess, 2008; Rubin & Fink, 2005). On the other hand, large amount of the emitted pMDI drug 
deposits in the oropharynx (Ari & Fink, 2011). In addition, many patients, especially young 
children, have trouble synchronizing the actuation and inhalation (Ari & Fink, 2011). To 
overcome the oropharynx deposition and/or synchronization issues, some patients use add-on 
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devices such as a spacer or a valved holding chamber. A spacer is simply a tube without a valve 
that captures aerosol from the pMDI (Hess, 2008). It reduces the amount of oropharynx 
deposition, but it still requires synchronicity between the actuation and the patient's inhalation 
(Rubin & Fink, 2005). By contrast, a valved holding chamber is a spacer device with a one-way 
valve that holds the medication until the patient's inhalation is initiated and the valve is opened, 
thus eliminating the need for synchronization between the actuation and patient's inhalation 
(Rubin & Fink, 2005). 
In tracheostomized patients, Newhouse (1999) reported that frequent actuation of a pMDI 
directly into a long term tracheostomy leads to minor hemoptysis and accumulation of 
granulation tissue on the carina and the adjacent bronchi. However, after placing an 
AeroChamber attached to an infant mask between the pMDI and the tracheal stoma, the 
pathologic changes and hemoptysis were gradually resolved. 
Several articles have described modifications to standard MDI spacers (Meeker & 
Stelmach, 1992; Mirza, Hopkinson, Malik, & Willat, 1999; Nakhla, 1997). All of these articles 
agree that current spacers do not easily fit onto a TT, which leads to inadequate drug delivery to 
the patients. Thus, simple modifications to standard MDI spacers are needed to make it easier to 
attach the spacer securely to the TT. All of the modifications to a standard pMDI presented in 
these articles were made to fit it to an adult TT. Monksfield (2008), in comparison, described the 
modification of a standard pMDI spacer for a pediatric TT. By using accessible materials such as 
a standard bladder irrigation syringe, he adapted a volumatic spacer (Allan and Hanburys) to fit 
firmly into a pediatric TT. After the center of the barrel's syringe had been cut, it snugly attached 
to the outflow end of the spacer because the barrel's diameter is appropriately the same size as 
the spacer's outflow end. Then, the end of the irrigation syringe was connected to the TT. When 
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Monksfield (2008) used this technique with his patient, compliance with bronchodilator therapy 
increased and the need for nebulized steroids in combination with bronchodilators decreased. 
In Vitro Comparisons 
Different types of nebulizers can be used to administer albuterol to pediatric patients with 
a tracheostomy. Berlinski and Hayden (2011) evaluated the effect of different aerosol devices on 
albuterol delivery in a spontaneously breathing pediatric tracheotomy model. The authors studied 
three different types of nebulizers: a continuous JN (Hudson), a BEN (Pari LC Plus) and a BAN 
(Aeroclipse II). All the nebulizers were tested with the following two TT sizes and two breathing 
patterns: tidal volume (Vt) = 80 ml, respiratory rate (RR) = 30 breaths/min, inspiratory to 
expiratory ratio (I:E) = 1:3 with a TT size of 3.5 mm and Vt= 310 ml, RR= 20 breaths/min, 
I:E=1:2 with a TT size of 5.5 mm. For the continuous JN, the authors studied three different 
configurations: the JN alone, the JN with 15 cm of corrugated tubing attached to it, and a JN 
connected to the corrugated tubing and a resuscitation bag. In each configuration, a T-piece and a 
tracheotomy mask were tested. However, only the T-piece was tested with both the BEN and the 
BAN. The albuterol deposition was collected via a filter placed at the carinal level of the 
tracha/Trach model and was analyzed via a spectrophotometer at a wavelength of 276 nm. The 
authors found almost no difference in albuterol deposition among the different configurations of 
JN when the tracheostomy mask interface was used. The authors also reported that the highest 
albuterol deposition occurred with the JN and T-piece in conjunction with the resuscitation bag 
followed by the JN with the corrugated tubing; the lowest albuterol deposition occurred when the 
JN was used alone (61±4, 39±8, and 25±3 µg, respectively, with a TT size of 3.5 mm; 71±23, 
60±12 and 43±12 µg, respectively, with a TT size of 5.5mm). Berlinski and Hayden also 
concluded that the T-piece was generally more efficient than the tracheostomy mask. 
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Furthermore, the researchers reported that the BEN was more efficient when tested with a larger 
Vt and a larger TT size (130±9 µg with Vt= 310 ml and a TT of 5.5 mm vs. 41±2 µg with Vt= 80 
ml and a TT of 3.5 mm). However, the BAN was inefficient when tested with a low Vt (4±2 µg). 
Although the authors studied different types of nebulizers, they did not compare the efficiency of 
each aerosol device with the others. Comparing the efficiency of different types of nebulizers can 
help to determine which is the most efficient for delivering aerosol to this population. 
Ari et al. (2010) conducted an in vitro study to assess the impact of the aerosol device (JN 
vs. VMN), position of the device on the ventilator circuit (prior to the humidifier vs. at the Y-
piece) and bias flow (2 vs. 5 L/min) on aerosol drug delivery in simulated and mechanically 
ventilated pediatric and adult lung models. The adult ventilator settings were as follows: a Vt of 
500 ml, a positive end expiratory pressure (PEEP) of 5 cmH2O, a RR of 20 breaths/min, a peak 
inspiratory flow (PIF) of 60 L/min and a descending ramp flow pattern. The pediatric ventilator 
settings were a Vt of 100 ml, a PEEP of 5 cmH2O, a RR of 20 breaths/min and an inspiratory 
time (Ti) of 1 second. The drug deposition was collected by an absolute filter distal to an 8 mm 
(adult) and 5 mm (pediatric) endotracheal tube. The amount of drug deposition was measured via 
spectrophotometry at a wavelength of 276 nm. Throughout this study, the VMN delivered the 
highest inhaled mass percentage (23.8% ± 1.0) in the adult lung model when it was placed prior 
to the humidifier with a 2 L/min bias flow. On the other hand, the JN delivered the least inhaled 
mass percentage (3.8% ± 0.3) in the pediatric lung model when it was placed at the Y-piece with 
a 5 L/min bias flow. In all positions, the inhaled mass of the VMN was two- to four fold greater 
than with the JN in both lung models. The authors also noted that using higher bias flow with 
both nebulizers tended to reduce aerosol drug delivery at both positions in the adult and pediatric 
lung models. Deposition of the aerosol was similar for both nebulizers when they placed the 
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devices at the Y-piece in the adult and pediatric lung models. When they placed the devices prior 
to the humidifier, they found that deposition of aerosol was higher for the VMN in the adult 
model than in the pediatric model. 
Piccuito and Hess (2005) conducted an in vitro study to assess the impact of the aerosol 
delivery device, interface, bias flow and humidification on albuterol delivery through a TT in a 
spontaneous breathing adult model. The researchers conducted two experiments. The first 
experiment used a nebulizer (Hudson, Temecula, CA) and the second used a pMDI (Monaghan, 
Plattsburgh, NY). In the nebulizer experiment, four conditions of gas flow and humidification 
were used. For the first condition, heated aerosol was generated using the nebulizer and a heater 
with an outlet flow of approximately 30 L/min. The relative humidity was > 95%. The second 
condition was heated humidity generated using a concha-Therm heated humidifier. The oxygen 
outlet flow was approximately 30 L/min. The researchers set the heat of the humidifier to 
provide a gas temperature of approximately 30˚C with a relative humidity > 95%. The third 
condition was high flow without added humidity (approximately 30 L/min). For the fourth 
condition, they attached the nebulizer to the TT without additional flow. In all four conditions, 
the nebulizer was filled with 4ml of 2.5 mg albuterol and tested with both a T- piece/flex tube 
and a tracheotomy mask. In the pMDI experiment, four conditions of gas flow and humidity 
were also used: (1) heated humidity with a T- piece, (2) heated humidity with a tracheostomy 
mask, (3) an AeroVent with a valved T-adapter, and (4) an AeroVent with a valved T-adapter 
and a one-way valve proximal to the AeroVent. In all of these four conditions, four actuations of 
the pMDI separated by ≥ 15 seconds were synchronized with the inhalation. In both experiments, 
the simulated adult breathing parameters were a RR of 20 breaths/min, a Vt of 400 ml, and an    
I:E of 1:2. A cuffed 8 mm TT was used. The aerosol delivered through the TT was captured by a 
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filter placed between the lung model and the distal end of the TT. This study had six major 
findings: (1) a measurable amount of albuterol aerosol was delivered through the TT with the use 
of either the nebulizer or the pMDI with a spacer; (2) the delivery of albuterol using the 
nebulizer with high gas flow was inefficient; (3) more albuterol was delivered  when they used a 
T-piece than when they used a tracheostomy mask; (4) the pMDI with a valved holding chamber 
was more efficient than the nebulizer; (5) the pMDI was more efficient when a T-piece with a 
valve was placed proximal rather than distal to the spacer; and (6) the impact of humidity on 
aerosol delivery was not clear. In conclusion, albuterol delivery through a TT was affected by the 
device, the interface and the bias gas flow. 
In an in vitro study, Ari et al. (2012) compared aerosol delivery through a TT and an 
endotracheal tube using different interfaces such as a tracheostomy mask, a T-piece and a 
manual resuscitation bag in a simulated spontaneously breathing adult model. They concluded 
that using the manual resuscitation bag increased lung dose by more than three- fold with either 
the TT or endotracheal tube (45.75 ± 1.8% vs. 27.23 ± 8.98%, p = 0.038 and p = 0.025, 
respectively). They also found that the tracheostomy mask had less inhaled dose than the T-piece 
with the TT (6.92 ± 0.81%, p = 0.01). Overall, the authors found that delivering aerosol through 
a TT was more efficient than through an endotracheal tube. 
Aerosol delivery via a pMDI to spontaneously breathing tracheostomy pediatric patients 
can be affected by many factors. Chavez and Berlinski (2010) conducted an in vitro study to 
investigate whether the delivery device, the size of the TT and the patient’s breathing pattern 
impact albuterol delivery via pMDI in a spontaneously breathing pediatric tracheostomy model. 
They examined several delivery devices: an AeroChamber MV™, an AeroChamber Mini™, an 
AeroTrach Plus™, a Medibag™, and a 6-inch tubing + Hudson™ adapter. These devices were 
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tested without bagging. With each device, two sizes of TT (3.5 and 4.5 mm) and three breathing 
patterns (16 months, 6 years old, and 12 years old) were tested. Furthermore, the Medibag™ and 
6-inch tubing + Hudson™ adapter were also studied with synchronized bagging, and the  
AeroChamber MV ™ was tested with both synchronized and asynchronized bagging. In all 
experiments, 10 pMDI actuations were delivered for six respiratory cycles each. The amount of 
albuterol was collected by a filter holder placed at the level of the carina. This amount was then 
measured via spectrophotometry at 276 nm. The authors reported that a smaller TT size, manual 
bagging and the breathing pattern of a younger child decreased the amount of albuterol reaching 
the carina. Moreover, the AeroTrach Plus™ was generally the most efficient delivery device. 
The effect of using a resuscitation bag on the delivery of aerosol via pMDI was further 
studied by Chavez, Holt, Heullit, and Berlinski (2011). In an in vitro study, they evaluated the 
effect of using a resuscitation bag in conjunction with a pMDI with a spacer during albuterol 
delivery in a spontaneously breathing pediatric tracheostomy model. They studied two types of 
valved holding chambers, an Aerochamber MV ™ and an AeroChamber Mini ™. Both valved 
holding chambers were tested using different albuterol administration techniques via pMDI: 
unassisted, synchronized assisted, and asynchronized assisted (on expiration or 1/s rate).  In all 
the tests, three different breathing patterns (16 months, 6 years old, and 12 years old) were 
simulated. In each test, 10 pMDI actuations were delivered for six repeated cycles through a 4.5 
mm TT. The authors reported that when synchrony and asynchrony (1s/rate) techniques were 
used, albuterol delivery decreased for all the devices and breathing patterns. When the 
researchers used asynchrony during expiration, albuterol delivery decreased only for the 16 
months old breathing pattern. The authors found that using a resuscitation bag with a pMDI 
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reduced the amount of aerosol delivered to the patients. This finding is similar to the previous 
study by Chavez and Berlinski (2010). 
In conclusion, this literature review has shown that there are many factors affecting the 
delivery of albuterol through a TT, including the aerosol delivery devices, interfaces, bias flows, 
administration techniques, and TT sizes used as well as the patients' breathing patterns. Several 
findings from the research stand out. The most commonly used aerosol delivery devices with a 
tracheostomy are nebulizers and pMDIs. However, research shows that a pMDI with a valved 
holding chamber is more efficient than a nebulizer. The AeroTrach Plus is generally the most 
efficient valved holding chamber for tracheostomy. BANs are inefficient when tested with low 
Vt. BENs are more efficient when tested with large Vt. In terms of bias flow, nebulizers with 
bias flow decreases albuterol delivery. In regard to interfaces, a T-piece is generally better than a 
tracheostomy mask. When administering albuterol using the assisted technique with a nebulizer 
increases albuterol delivery. On the other hand, using the assisted technique with a pMDI 
decreases albuterol delivery. In regards to TT size, the amount of the albuterol delivery decreases 
as the size of the TT decreases. Finally, breathing patterns affect delivery, with albuterol delivery 
decreases among younger children. 
 
 
 
 
 
 
 
14	  
	  
CHAPTER III  
METHODOLOGY  
Experimental Setup  
As shown in Figure 1, to simulate spontaneous breathing for a two-year-old child with a 
tracheostomy tube (TT), one side of a dual-chamber test lung with a lift bar (Training/test lung 
[TTL] PneuView Systems, Adult/infant lung simulator, Michigan Instruments, Grand Rapids, 
MI)  was connected to the ventilator (Hamilton Medical AG, Rhäzüns, Switzerland). The other 
side of the test lung was connected to the TT. Breathing parameters were set at an RR of 25 
breaths/min, a Vt of 150 ml, a Ti of 0.8 second, and a PIF of 20 L/min (Lin et al., 2012). An 
uncuffed TT (Shiley™, Covidien IIc, Mansfield, MA) with an inner diameter of 4.5 mm was 
used because previous research has found it to be suitable for a two-year-old child (Wyatt, 
Bailey, & Whiteside, 1999). The TT was attached to the collecting filter (Respirgard II, 303, vital 
signs, Brooklyn, NY). Another filter was placed between the collecting filter and the opposite 
side of the dual-chamber test lung to protect the test lung. The same experimental setup was used 
in each trial of this study. 
 
 
 
 
 
 
 
Figure 1. Experimental setup of the study. 
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Aerosol Devices types, Doses and Operation 
Three types of aerosol devices were tested in this study: (1) a JN (Micro Mist, Hudson 
RCI, Temecula, CA), (2) a VMN (Aeroneb Solo, Aerogen, Galway, Ireland) and (3) a pMDI 
(ProAir HFA, Teva Specialty Pharmaceutical, Horsham, PA). 
The nebulizers (JN and VMN) were filled with albuterol sulfate (2.5mg/3 ml) (Nephron 
Pharmaceuticals Corporation, Orlando, FL). The JN was operated with oxygen at 8 L/min, using 
a calibrated flow meter. The unit-dose of albuterol sulfate solution was aerosolized by the JN 
until the onset of sputter and by the VMN until no more aerosol was seen. 
The pMDI canister, which contained albuterol sulfate (108 µg/actuation) was warmed to 
hand temperature, shaken well, and primed with four actuations before each experimental run. 
The pMDI was actuated at the onset of inspiration for a total of four puffs with more than15 
seconds between each. All actuations were activated by the same investigator to minimize inter-
operator variability. Each experiment was repeated five times. 
Administration Techniques 
 In this study, aerosol therapy was administered to the spontaneously breathing model 
using two techniques: 1) assisted technique using a manual resuscitation bag in conjunction with 
an aerosol device and 2) unassisted technique with direct administration from the aerosol device.  
Unassisted Technique Setup 
JN and VMN were administered as shown in Figure 2A and 2B, respectively. The T-
piece of the nebulizers was connected to another T-piece which was attached to the TT.  A 6-
inch length of 22 mm ID corrugated tubing was placed on both open ends of the T-pieces. 
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 The pMDI was removed from the actuator and inserted into the nozzle inlet of a spacer 
(Aerochamber HC MV, Trudell, London, Ontario, Canada). The pMDI + spacer was then 
connected to the proximal part 15 mm adapter of the TT (Figure 2C). 
Assisted Technique Setup 
In the assisted technique, both JN and VMN were attached to a manual resuscitation bag 
(Ambu SPUR II Disposable Resuscitator, Ambu Inc, Glen Burnie, MD) via a T-piece adaptor 
that was connected to the TT through a 6-inch length of corrugated tube (Figure 2D and 2E, 
respectively). The manual resuscitation bag was manually squeezed in synchrony with each 
inspiration of the model. To ensure consistency with the spontaneous breathing model, all 
breaths via the manual resuscitation bag were administered by a single investigator. 
The pMDI + spacer was connected between the manual resuscitation bag and the TT. 
(Figure 2F). Each actuation was synchronized with the beginning of inspiration. To ensure 
consistency with the spontaneous breathing model, all pMDI actuations and the bagging were 
delivered by the same investigator. 
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Figure 2. Experimental setup with each aerosol device using assisted and unassisted techniques. 
JN: Jet Nebulizer. VMN: Vibrating Mesh Nebulizer. pMDI: Pressurized Metered Dose Inhaler. 
 
Measurement of Aerosol Deposition 
Each aerosol device was tested five times using both administration techniques (n=5) 
(Figure 3). In each trial, the amount of aerosol exiting the TT was captured by an absolute filter. 
At the end of each trial, the deposited drug was eluted from the filter with 10 ml of 0.1 N 
hydrochloric acid (JT Baker Company, Phillipsburg, NJ) using gentle agitation for 1 minute to 
ensure proper mixing. The albuterol concentration was then analyzed with a spectrophotometry 
(Beckman Instruments, Fullerton, CA) using a quartz cuvette, at a wavelength of 276 nm. The 
spectrophotometer was calibrated prior to the trials via a holmium oxide filter (Beckman 
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Instruments, Fullerton, CA) to determine wavelength accuracy. It was then set to zero before the 
next trial by running only the solvent. 
 
 
 
 
 
 
 
 
 
Figure 3. Organizational design of the study. 
 
Data Analysis 
The amount of drug deposited in the filter was quantified and reported as inhaled mass 
and inhaled mass percentage. Data analyses were performed using the Statistical Package for the 
Social Sciences (IBM SPSS, 18.0, Chicago, IL). Descriptive statistics including means and 
standard deviations were computed for each aerosol device (JN, VMN, pMDI) for both the 
assisted and unassisted techniques. A repeated measures test was performed to determine the 
difference in the inhaled mass and inhaled mass percentage among the JN, the VMN and pMDI, 
all together. Multiple comparisons were done to identify differences between aerosol devices 
tested in this study using the assisted and unassisted techniques. A paired t-test was used to 
  JN 
Aerosol Drug Delivery 
Assisted Technique Unassisted Technique 
  JN VMN pMDI 
 n=5  n=5  n=5 
VMN pMDI 
 n=5  n=5  n=5 
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compare the	  assisted with unassisted techniques on inhaled mass and inhaled mass percentage for 
each aerosol device. In all comparisons, significance was defined as a p value < 0.05. 
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CHAPTER IV 
RESULTS 
This study compared the amount of aerosol delivered to the TT (the inhaled mass) and 
the inhaled mass percentage of three devices–a JN, aVMN, and a pMDI– using both an assisted 
and unassisted techniques. Table 1 presents the means (± standard deviation) of albuterol mass 
deposited on the filter and percent of nominal dose for JN and VMN and emitted dose for 4 
actuations from the pMDI using the assisted and unassisted techniques. 
 
Table 1. 
 
Efficiency of Aerosol Devices on Drug Delivery 
This study found differences in the inhaled mass and inhaled mass percentage among the 
three aerosol devices (p= 0.0001). There was also a statistically significant difference in the 
inhaled mass and inhaled mass percentage between the JN and the VMN as well as between the 
VMN and the pMDI when using both the assisted (p= 0.000, and p= 0.006, respectively) and the 
unassisted techniques (p= 0.002, p= 0.004, respectively). The findings of this study showed no 
significant difference between the JN and the pMDI in terms of inhaled mass when using either 
 Inhaled Mass (mg) Inhaled Mass Percent (%) 
JN VMN pMDI JN VMN pMDI 
  Assisted 
Technique 
0.13 ± 0.03 0.43 ± 0.03 0.18 ± 0.05 5.31 ± 1.59 17.45 ± 1.26 43.32 ± 12.38 
Unassisted 
Technique 
0.15 ± 0.01 0.49 ± 0.07 0.20 ± 0.03 5.88 ± 0.77 19.77 ± 2.99 47.15 ± 7.82 
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the assisted or unassisted technique (p=0.481, p=0.080, respectively). For inhaled mass 
percentage, however, the difference was statistically significant when using both the assisted and 
unassisted techniques (p= 0.008, p= 0.001, respectively). As shown in Table 1, the highest 
inhaled mass was with the VMN, while the inhaled mass efficiency was greatest with the pMDI. 
The JN was the least efficient device in both inhaled mass and inhaled mass percentage (Figure 4 
and 5, respectively).  
Efficiency of Aerosol Administration Techniques on Drug Delivery 
While there was a trend towards higher inhaled mass and inhaled mass percentage with 
unassisted vs. assisted technique, the differences between the two techniques were not 
statistically significant for the JN, VMN and pMDI (p= 0.46, p= 0.19, and p= 0.64, respectively). 
 
 
 
 
 
 
 
 
 
Figure 4. Differences in inhaled mass among aerosol delivery devices by delivery technique.  
 
 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
JN VMN pMDI
In
ha
le
d	  
M
as
s	  
(µ
g)
Aerosol	  Delivery	  Device
Assisted	  Technique
Unassisted	  Technique
22	  
	  
 
 
 
 
 
 
 
 
Figure 5. Differences in inhaled mass percentage among aerosol delivery devices by delivery 
technique.  
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CHAPTER V 
DISCUSSION 
The purpose of this study was to evaluate the efficiency of the aerosol devices and the 
administration techniques on the drug delivery to spontaneously breathing pediatrics with TT. 
The percent of albuterol deposited distal to the TT was greater with the pMDI than VMN or JN. 
The VMN was three fold more efficient than JN. In terms of administration technique, there was 
no statistically significant difference on aerosol deposition between assisted and unassisted 
techniques.  
Efficiency of aerosol devices on drug delivery 
 When the pMDI was compared with the JN, we found that despite the smaller nominal 
dose of the pMDI (432 µg) than the JN (2.5 mg), the amount of drug delivered to the TT was 
more with the pMDI than the JN. These data are supported by Piccuito and Hess (2005), who 
compared aerosol delivery between the JN and the pMDI in several conditions to the 
spontaneously breathing adult with tracheostomy. In their study, they found that pMDI is more 
efficient than JN in relation to the percentage of inhaled mass (21 ±1% vs. 15 ± 3%, p= 0.002). 
However, they reported that the amount of inhaled mass was greater with JN than pMDI (382 ± 
68 µg vs. 84 ± 4µg, p < 0.001), while this study found the opposite. The difference in the amount 
of inhaled mass may attribute to the difference in the amount of fill volume in the JN given in 
each study. The amount of fill volume of their study was 2.5 mg/4ml, while in this study was 
2.5mg/3ml. According to Hess, Fisher, Williams, Pooler, and Kacmarek (1996) study, increasing 
the amount of fill volume by adding more diluent volume will decrease the amount of drug 
remaining in the JN after treatment ends and will increase the amount of inhaled medication. 
Therefore, the higher fill volume in the JN of Piccuito and Hess study lead to an increase in the 
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amount of the inhaled mass obtained by using the JN than our study. Additionally, the 
administration setup of the JN was different between these two studies. Piccuito and Hess capped 
one end of the JN’s T-piece, while the other end was attached to the T-piece interface via 15 cm 
flex tube. In this study, one end of the JN’s T–piece was attached to the corrugated tube while 
the other was connected to the T piece interface (Figure 2A). Capping one end of the JN’s T-
piece will increase the amount of the inhaled medication. This difference in the setup of the JN 
administration contributes also to having higher inhaled mass with the JN in Piccuito and Hess 
than this study.  
When the VMN is compared to the JN, this study found that VMN is three fold more 
efficient than JN. This result agrees with the findings of Ari et al. (2010), who evaluated aerosol 
drug delivery in pediatric mechanically ventilated lung model with endotracheal tube. They 
compared JN and VMN in different positions and bias flows. They found that drug delivery with 
VMN was 2-4 fold greater than JN in pediatric lung models regardless of position and bias flow. 
However, the inhaled mass percent of the JN and the VMN in their study was lower than this 
study. This difference is not surprising since the type of the population tested in this study is 
spontaneously breathing whereas mechanically ventilated in their study. Dolovich, Killian, 
Wolff, Obminski, and Newhouse (1977) reported that the mean of the amount of aerosol 
deposited in the lung with intermittent positive pressure ventilation was less than quite breathing 
by 32% despite having the same drug dose in the ultrasonic nebulizer. Another factor that may 
also attribute to the difference in the amount of aerosol deposition between these studies is the 
type of the artificial airway used. This study used TT, while they used endotracheal tube. The TT 
is shorter than the endotracheal tube which means lesser drugs will be lost in the tube. Ari et al. 
(2012) reported that the TT is more efficient than the endotracheal tube in terms of drug delivery.  
25	  
	  
Efficiency of aerosol administration techniques on drug delivery 
This study found that adding a manual resuscitation bag to the aerosol device when 
administrating bronchodilator (assisted technique) does not increase the amount of deposited 
drug on the TT with all the studied aerosol devices. This result differs from the findings of Ari et 
al. (2012). In an in vitro study, they evaluated the effect of using different patient interfaces such 
as T-piece, tracheostomy collar and manual resuscitation bag on aerosol drug delivery through 
TT and endotracheal tube. They concluded that using the manual resuscitation bag increased 
lung dose by more than three fold with either TT or endotracheal tube. This difference may 
account for the difference in breathing parameters, tracheostomy tube size and nebulizer type 
used in both studies. While Ari et al (2012) used adult breathing parameters (Vt= 450 mL, RR= 
20 breaths/min, I:E ratio 1:2) with 8 mm TT size, this study used pediatric breathing parameters 
suitable for a 2 years old child (RR= 25 breaths/min, Vt= 150 ml, Ti= 0.8 second, and PIF= 20 
L/min) with 4.5 mm TT size. The smaller Vt and higher RR with a smaller diameter TT would 
be expected to reduce the amount drug deposited distal to the airway. They also used evalueMed 
nebulizer, while this study used Hudson MicroMist nebulizer. Having different brands of 
nebulizer may also account for the difference in the amount of deposited drugs.  
Clinical Implications 
This study provides good guidance to clinicians or caregivers regarding the relative 
efficiency of these three aerosol delivery devices and the two administration techniques used 
when administering aerosol therapy to spontaneously breathing pediatrics via TT. For the type of 
aerosol delivery devices, the pMDI or VMN should be the first selection, making the selection of 
the JN last option. However, there is no difference between assisted and unassisted aerosol 
administration techniques when using any one of the aerosol devices. Consequently, 
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administration technique selection can be determined by the patient comfort level, the need to 
augment ventilation with a manual resuscitation bag for the specific patient. 
Limitations 
This experiment was an in vitro study. Thus, the results should be validated by an in vivo 
study. In addition, the in vivo study provides more clinical responses in pediatric patients 
receiving aerosol therapy with different aerosol devices and administration techniques. This 
study only examined one type and size of the TT and resuscitation bag, as well as one set of 
breathing parameters. 
Future Research 
For future studies, we suggest studying the effect of administration technique on aerosol 
delivery to the pediatric patients by using other types of resuscitation bags, such as a flow 
inflating bag. Different breathing patterns should be also studied in order to determine how 
aerosol deposition would be affected by different diseases and patient conditions.  
Conclusion 
In this in vitro spontaneously breathing pediatric model, drug deposited distal to the TT 
was influenced by the type of aerosol device used. JN was the least efficient device than both 
VMN and pMDI. However, drug efficiency was similar with assisted and unassisted aerosol 
administration techniques. The findings of this study could provide clinical guidance to the 
health care providers or caregivers in selecting the best method to optimize drug delivery to 
pediatric patients with TT. 
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